NCT07096999View on ClinicalTrials.gov

SPECT/CT Imaging for Dosimetry in 177Lu-PSMA-617 (Pluvicto) Therapy

RecruitingOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

January 23, 2025

Primary Completion Date

January 23, 2031

Study Completion Date

January 23, 2031

Conditions
Metastatic Castration-Resistant Prostate Carcinoma
Interventions
OTHER

Non-Interventional Study

Non-interventional study

Trial Locations (1)

48109

RECRUITING

University of Michigan Comprehensive Cancer Center, Ann Arbor

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University of Michigan Rogel Cancer Center

OTHER

NCT07096999 - SPECT/CT Imaging for Dosimetry in 177Lu-PSMA-617 (Pluvicto) Therapy | Biotech Hunter | Biotech Hunter